| 91 |
Assessment of hepatitis E virus (HEV) in the edible goat products pointed out a risk for human infection in Upper Egypt |
2020 |
| 92 |
Assessment of hepatitis E virus (HEV) in the edible goat products pointed out a risk for human infection in Upper Egypt |
2020 |
| 93 |
Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients |
2020 |
| 94 |
Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients |
2020 |
| 95 |
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects |
2020 |
| 96 |
Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium) |
2020 |
| 97 |
Bioactive fluorenes. Part III: 2,7-dichloro-9 H-fluorene-based thiazolidinone and azetidinone analogues as anticancer and antimicrobial against multidrug resistant strains agents
|
2020 |
| 98 |
Biogenesis, Biologic Function and Clinical Potential of Exosomes in Different Diseases |
2020 |
| 99 |
Circulation of hepatitis E virus (HEV) and/or HEV-like agent in non-mixed dairy farms could represent a potential source of infection for Egyptian people |
2020 |
| 100 |
Circulation of hepatitis E virus (HEV) and/or HEV-like agent in non-mixed dairy farms could represent a potential source of infection for Egyptian people |
2020 |